This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torrentera, F. A.
Right arrow Articles by Carlier, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torrentera, F. A.
Right arrow Articles by Carlier, Y.

 Previous Article  |  Next Article 

Infection and Immunity, January 2001, p. 617-621, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.617-621.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

T-Cell Responses to Immunodominant LACK Antigen Do Not Play a Critical Role in Determining Susceptibility of BALB/c Mice to Leishmania mexicana

Fabiola Aguilar Torrentera,1,2,dagger Nicolas Glaichenhaus,3 Jon D. Laman,4 and Yves Carlier1,*

Laboratoire de Parasitologie, Université Libre de Bruxelles (ULB), Brussels, Belgium1; Institut de Pharmacologie Moléculaire et Cellulaire, CNRS, Valbonne, France3; Department of Immunology, Erasmus University Rotterdam (EUR), Rotterdam, The Netherlands4; and Departamento de Inmunologia, Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City, Mexico2

Received 17 July 2000/Returned for modification 8 September 2000/Accepted 23 October 2000


    ABSTRACT
Top
Abstract
Text
References

Although BALB/c mice develop lesions when infected with Leishmania mexicana, the mechanisms which are responsible for susceptibility to this parasite have not been elucidated. In contrast, susceptibility of BALB/c mice to Leishmania major has been shown to depend on the early production of interleukin-4 (IL-4) by T cells which react to the parasitic LACK antigen. Here, we demonstrate that the lesions induced by L. mexicana are delayed compared to those induced by L. major but rapidly develop at later time points. Interestingly, while LACK-tolerant BALB/c-derived IE-LACK transgenic mice were resistant to L. major, they were susceptible to L. mexicana and developed lesions similar to those observed in wild-type BALB/c mice. The latter result was observed despite the fact that (i) LACK was expressed by L. mexicana, (ii) splenocytes from BALB/c mice were able to stimulate LACK-specific T-cell hybridoma cells when incubated with live L. mexicana promastigotes, and (iii) LACK-specific T cells contributed to IL-4 production in L. mexicana-infected BALB/c mice. Thus, in contrast to what was observed for L. major-infected mice, LACK-specific T cells do not play a critical role in determining susceptibility to L. mexicana. Although BALB/c mice are susceptible to both L. major and L. mexicana, the mechanisms which are responsible for susceptibility to these parasites are likely to be different.


    TEXT
Top
Abstract
Text
References

Mice have been widely used as an animal model to study human leishmaniasis. In many cases, the outcome of the disease is different depending on the strains which are infected. In the case of mice infected with Leishmania major, it has been shown that CBA, C3H, C57BL/6, and B10.D2 mice develop cutaneous lesions that spontaneously heal, while BALB/c, SWR/J, DBA/2, and A/Jax mice develop nonhealing cutaneous lesions which are susceptible to dissemination (4, 20). Several studies have shown that the early production of interleukin-4 (IL-4), which is induced in the draining lymph nodes (LNs) of BALB/c mice 16 h after infection with L. major, is one of the critical events leading to the development of a counterprotective antiparasite Th2 response (5, 10, 12-14). IL-4 is produced by CD4+ T cells which express a highly restricted Vbeta 4 Valpha 8 receptor repertoire (11). These cells recognize a single parasite determinant derived from the antigen LACK (leishmania receptor for activated C kinase, for its homology with the mammalian receptors for activated C kinase [RACK]), a protein which is conserved among different Leishmania spp. and which accounts for 0.03% of the proteins expressed by Leishmania promastigotes or amastigotes (14, 17, 18). The critical role of the LACK-specific T cells in determining susceptibility to L. major is further demonstrated by the observation that BALB/c mice which have been made tolerant to LACK are resistant to infection (9, 11).

Although studies have shown that IL-4 is critical for susceptibility to Leishmania mexicana (23-25), it is not known whether LACK-specific T cells play a critical role in the animal model for this infection. To address this issue, we have compared the courses of L. mexicana and L. major infections in wild-type (WT) BALB/c mice and in BALB/c-derived IE-LACK transgenic mice which are tolerant to LACK as the result of its constitutive expression in the thymus. In contrast to what was observed for L. major-infected mice, we found that LACK-specific T cells do not seem to play a critical role in determining the susceptibility of BALB/c mice to L. mexicana infection.

BALB/c male mice (8 to 12 weeks old) were purchased from Banting & Kingman Universal Limited (Hull, United Kingdom). IE-LACK transgenic mice have been previously described (9). L. mexicana (strain MHOM/BZ/82/BEL21) and L. major (strain WHOM/IR/-173) promastigotes were grown in RPMI medium (Life Technologies, Merelbeke, Belgium) supplemented with 10% fetal calf serum (Life Technologies), penicillin G (100 U/ml), and streptomycin (100 µg/ml). Promastigote lysates were prepared by 10 cycles of freezing (in liquid nitrogen) and thawing (in a water bath at 37°C), and their endotoxin contents were lower than 0.20 pg/106 promastigotes as determined by the Limulus amebocyte lysate-Coatest endotoxin assay (Chromogenix, Mölndal, Sweden). The LACK-derived peptide, previously identified as an immunodominant epitope in BALB/c mice (amino acids 161 to 172, of sequence SLEHPIVVSGSW) (17), was obtained from Chiron Mimotopes (Paris, France) and from P. Gourlet (Laboratory of Biochemistry, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium). The LACK-specific T-cell hybridoma LMR16.2, producing IL-2 upon recognition of the immunodominant L. major LACK epitope in an I-Ad major histocompatibility complex class II-restricted fashion, was used as previously described (17). IL-2 and IL-4 levels were determined by enzyme-linked immunosorbent assays using commercially available kits (duoset from Genzyme Diagnostics, Cambridge, Mass.). The limit of detection was 5 pg/ml for both cytokines.

Diseases induced by L. mexicana and L. major in BALB/c mice. Although BALB/c mice are known to be susceptible to both L. major and L. mexicana (1), the diseases induced by these two species have not been compared under the same experimental conditions. In our study, L. mexicana or L. major promastigotes were injected into the left footpad of BALB/c mice. Each mouse received 107 stationary-phase promastigotes in a final volume of 25 µl of RPMI medium. The contralateral right footpad received an identical volume of RPMI medium, without parasites, as an internal control. Footpad thicknesses were measured with a metric caliper, and the difference between both measurements corresponded to lesion size. As shown in Fig. 1, while L. mexicana induced slowly progressive primary lesions which reached 10 to 11 mm after 34 weeks, L. major induced the rapid development of lesions which were 4 to 5 mm thick at 4 weeks postinfection (wpi). The cutaneous lesions induced by L. major became ulcerated more frequently and earlier than those induced by L. mexicana. Likewise, L. major, but not L. mexicana, induced spontaneous losses (mutilations) of necrotic footpad lesions which could not be measured after 14 weeks (Fig. 2A). While both L. mexicana and L. major induced secondary lesions which appeared in the contralateral posterior or anterior footpads, the eyelids, the nostrils, the ears, and the base of the tail, these lesions developed later in mice infected with L. mexicana than in those infected with L. major (Fig. 2B). Thus, while BALB/c mice were susceptible to both L. major and L. mexicana infections, the courses of disease induced by these two parasites were markedly different.


View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1.   Sizes of primary footpad lesions of BALB/c mice infected with L. mexicana or L. major. Results are from one representative experiment performed with 28 (L. mexicana) and 15 (L. major) animals and are expressed as means ± SEM. **, P < 0.001 (Student's t test, comparing L. mexicana and L. major infections). Three other experiments using 15, 16, and 12 animals infected with L. mexicana displayed similar results. This was also the case for another experiment including 10 mice infected with L. major.


View larger version (28K):
[in this window]
[in a new window]
 
FIG. 2.   Frequencies of ulcerated cutaneous primary lesions and mutilations of footpads (A) and cutaneous secondary lesions (B) during the course of L. mexicana and L. major infections in BALB/c mice. Results are from the same experiment described for Fig. 1. nd, not determined.

Stimulation of a LACK-specific T-cell hybridoma by BALB/c splenocytes incubated with L. mexicana live promastigotes. To determine if antigen-presenting cells could process the L. mexicana LACK antigen and present it to T cells, splenocytes from BALB/c mice were incubated in 96-well plates (Nunc, Roskilde, Denmark) with the LACK-specific T-cell hybridoma LMR16.2 and L. mexicana or L. major live or lysed promastigotes. In some wells, splenocytes (5 × 105/well) were incubated with either live L. mexicana or L. major promastigotes for 6 h at 37°C. Other splenocyte-containing wells received L. mexicana or L. major lysate (at the corresponding parasite/splenocyte ratios used for live parasites) or the LACK-derived peptide (at concentrations ranging from 0.2 to 25.6 µM). The LMR16.2 hybridoma cells (105/well) were added to each well. Twenty hours later, cellular supernatants were harvested for subsequent measurement of IL-2 levels.

LACK peptide (data not shown) and both L. major and L. mexicana promastigotes (Fig. 3) induced the LMR16.2 hybridoma cells to secrete IL-2 in a dose-dependent manner. The fact that splenocytes incubated with L. mexicana promastigotes could stimulate the LMR16.2 T-cell hybridoma recognizing specifically the L. major LACK antigen suggested that the antigenic determinant which was recognized by these LACK-specific cells was conserved between the L. mexicana and L. major LACK proteins.


View larger version (19K):
[in this window]
[in a new window]
 
FIG. 3.   IL-2 secretion by LMR16.2 hybridoma cells in response to L. major and L. mexicana promastigotes. Splenocytes from BALB/c mice were incubated with LMR16.2 hybridoma cells and with live (A) or lysed (B) L. mexicana or L. major promastigotes. Results are expressed as means ± SEM of IL-2 levels released in culture supernatants for three experiments. *, P < 0.05 (Student's t test, comparing L. mexicana and L. major).

Interestingly, while the L. mexicana and L. major lysed promastigotes did not differ in the ability to stimulate LMR16.2 hybridoma cells (Fig. 3B), L. mexicana live promastigotes induced less IL-2 than L. major live promastigotes (Fig. 3A). Though slight, such differences were significant and might be related to differences in the proportion of metacyclic-like promastigotes (the parasitic form infecting cells) within the L. major and L. mexicana stationary-phase populations (22) or to differences in the intracellular development of both parasites, interfering with antigen presentation (19). Indeed, the tight binding of L. mexicana amastigotes to the membrane vacuole of infected macrophages, which is not seen with L. major amastigotes (2), and the sequestration of major histocompatibility complex class II molecules at this point of the membrane (rendering difficult their egress from the parasitophorous vacuole) (21), as well as the production of large amounts of cysteine proteases by L. mexicana (8, 16) but not L. major, are likely to reduce antigen processing and presentation of the L. mexicana LACK antigen.

Molecular identification of the LACK epitope in L. mexicana. In order to confirm that the antigenic epitope recognized by the LACK-specific cells was conserved between the L. mexicana and L. major LACK proteins, cDNA was prepared from RNA of L. mexicana promastigotes, and the sequence corresponding to the immunodominant LACK epitope was amplified by PCR using the following primers: LM12 (TCCATCCGCATGTGGGACCTG) and LM13 (CCCGTTCACGTTCCATACTTTG) (17). The nucleotide sequence of the L. mexicana PCR products, determined using standard procedures, was identical to that of the corresponding L. major region (data not shown). This confirms that the parasite LACK antigen is well conserved among the different studied Leishmania species, including L. major, Leishmania amazonensis, Leishmania donovani, Leishmania chagasi (17), and L. mexicana.

Susceptibility to L. mexicana of BALB/c mice made tolerant to LACK protein. Since LACK-specific T cells play a critical role in determining susceptibility to L. major, we sought to determine if this was also the case for L. mexicana infection. To this end, IE-LACK transgenic and WT BALB/c mice were injected with 107 promastigotes. In agreement with previous results (9), the lesions induced by L. major were much smaller in IE-LACK transgenic mice than in WT BALB/c mice (Fig. 4B). In contrast, the lesions induced by L. mexicana were similar in transgenic and nontransgenic animals (Fig. 4A). Likewise, parasite loads in the footpads and in the draining popliteal LNs (measured after tissue homogenization by staining released amastigotes with acridine orange [Sigma, Bornem, Belgium], as previously reported for Plasmodium and Leishmania promastigotes [3, 15]), as well as the frequencies of both necrotic and secondary cutaneous lesions, were similar for IE-LACK transgenic and WT BALB/c mice (Table 1). Thus, despite the fact that BALB/c splenocytes were able to stimulate LACK-specific T cells when incubated with L. mexicana promastigotes, IE-LACK transgenic mice tolerant to the LACK antigen were as susceptible as WT BALB/c mice to L. mexicana infection. This might be related to the reduced ability of L. mexicana live promastigotes to stimulate LACK-specific T cells, as shown in our experiment with LMR16.2 hybridoma cells. Moreover, since the processing of LACK by infected macrophages requires the destruction of the internalized parasites (6, 19), differences in the innate immune responses to L. mexicana and L. major and in the subsequent early production of cytokines activating the parasiticidal function of macrophages may also account for this result.


View larger version (13K):
[in this window]
[in a new window]
 
FIG. 4.   Sizes of primary footpad lesions during the course of L. mexicana (A) or L. major (B) infection in IE-LACK (LACK-TgBALB/c) and WT BALB/c mice. Results are expressed as means ± SEM. Twelve male mice per group were inoculated. **, P < 0.001 (Student's t test, comparing IE-LACK and WT animals).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Parasitic loads and frequencies of lesions in mice infected with L. mexicana

IL-4 secretion by splenocytes of IE-LACK transgenic and WT BALB/c mice infected with L. mexicana. Although IE-LACK transgenic mice were as susceptible as WT BALB/c mice to L. mexicana, we sought to determine if LACK-specific T cells contributed to IL-4 secretion in L. mexicana-infected mice. To this end, splenocytes of IE-LACK transgenic and WT BALB/c mice infected with 107 L. mexicana promastigotes were harvested at 0, 2, 6, and 14 wpi and incubated in 24-well plates (Nunc) (3 × 106 cells/800 µl/well) at 37°C for 48 h in a 5% CO2 humidified atmosphere, with or without concanavalin A (8 µg/well; Sigma) or L. mexicana extracts (106 lysed parasites/well). Supernatants of unstimulated or stimulated cells were collected for subsequent determination of IL-4 levels. Concanavalin A stimulated splenocytes to produce IL-4 (100 to 390 pg/ml) at each time point for both mouse groups. Neither splenocytes from naive animals nor those from mice which had been infected 2 or 6 weeks earlier produced IL-4 in response to L. mexicana lysates. This agrees with previous studies which have shown that IL-4 transcripts are undetectable in the LNs and the spleens of L. mexicana-infected mice 1 and 7 days after infection (7). In contrast, when mice were analyzed 14 weeks after infection, splenocytes from both IE-LACK transgenic and WT BALB/c mice secreted IL-4 in response to parasite extracts. However, splenocytes from IE-LACK transgenic mice secreted significantly less IL-4 than those from WT BALB/c mice. (Means ± standard errors of the means [SEM] for stimulated cells were as follows: IE-LACK mice, 56 ± 9 pg/ml; WT mice, 179 ± 65 pg/ml [P < 0.05 by Student's t test, n = 3]. The results for unstimulated cells were as follows: IE-LACK mice, 11 ± 8 pg/ml; WT mice, 29 ± 15 pg/ml.) Such a difference suggests that LACK-specific T cells contributed to the production of IL-4 in L. mexicana-infected WT mice.

In conclusion, despite BALB/c splenocytes being able to stimulate LACK-specific T cells, which contribute to the production of IL-4 in L. mexicana-infected mice, and despite the fact that IL-4 was shown to be required for susceptibility to L. mexicana (23), IE-LACK transgenic mice tolerant of LACK antigen were as susceptible as WT BALB/c mice to L. mexicana infection. This indicates that LACK-specific T cells do not play a critical role in determining susceptibility to L. mexicana. This result is in striking contrast to those obtained in the case of BALB/c mice infected with L. major. It is tempting to hypothesize that such a difference preventing the development of an early counterprotective antiparasite Th2 response contributes to the slower development of lesions in L. mexicana-infected animals. It also suggests that the mechanisms which determine susceptibility to these two species are markedly different.


    ACKNOWLEDGMENTS

F.A.T. was supported successively by Ph.D. fellowships from the Comission de Operaciones para el Fomento Academico y Administrativo (COFA) of the Instituto Politecnico Nacional (Mexico) and ULB. This work was supported by grants of the Belgian Ministry of Scientific Policy ("Action de Recherche Concertée") and ULB.

We thank C. Truyens for advice and for measuring endotoxin contents and D. Le Ray (Institut of Tropical Medicine, Antwerp, Belgium) for giving us the MHOM/BZ/82/BEL21 strain of L. mexicana. We are indebted to C. Truyens, E. Muraille, and J.-C. Antoine for their critical review of the manuscript and to A. Wathelet, P. Delblandre, K. Mjidi, and A. Ben Messaoud for their diligent technical assistance.


    FOOTNOTES

* Corresponding author. Mailing address: Laboratoire de Parasitologie, Faculté de Médecine, ULB, CP 616, Route de Lennik 808, B-1070 Brussels, Belgium. Phone: 32 2 555 62 55. Fax: 32 2 555 61 28. E-mail: ycarlier{at}ulb.ac.be.

dagger Present address: Escuela Nacional de Ciencias Biologicas, Instituto Politecnico Nacional, Mexico City, Mexico.

Editor:   J. M. Mansfield


    REFERENCES
Top
Abstract
Text
References

1. Alexander, J., and P. M. Kaye. 1985. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections. Clin. Exp. Immunol. 61:674-682[Medline].
2. Antoine, J. C., E. Prina, T. Lang, and N. Courret. 1998. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends Microbiol. 6:392-401[CrossRef][Medline].
3. Barreca, G. S., M. C. Berlinghieri, F. Foti, G. Matera, and A. Foca. 1997. Microscopic observation of progressive immobilization of leishmania promastigotes in acridine orange stain. J. Clin. Microbiol. 35:1867-1869[Abstract].
4. Bradley, D. J. 1987. Genetics of susceptibility and resistance in the vertebrate host, p. 551-581. In W. Peters, and R. Killick-Kendrick (ed.), The leishmaniases in biology and medicine. Academic Press, London, United Kingdom.
5. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182-1187[Abstract].
6. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773[CrossRef][Medline].
7. Guevara-Mendoza, O., C. Une, C. P. Franceschi, and A. Orn. 1997. Experimental infection of Balb/c mice with Leishmania panamensis and Leishmania mexicana: induction of early IFN-gamma but not IL-4 is associated with the development of cutaneous lesions. Scand. J. Immunol. 46:35-40[CrossRef][Medline].
8. Ilg, T., M. Fuchs, V. Gnau, M. Wolfram, D. Harbecke, and P. Overath. 1994. Distribution of parasite cysteine proteinases in lesions of mice infected with Leishmania mexicana amastigotes. Mol. Biochem. Parasitol. 67:193-203[CrossRef][Medline].
9. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421-423[Abstract/Free Full Text].
10. Kopf, M., F. Brombacher, G. Kohler, G. Kienzle, K. H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4-deficient Balb/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127-1136[Abstract/Free Full Text].
11. Launois, P., I. Maillard, S. Pingel, K. G. Swihart, I. Xenarios, H. Acha-Orbea, H. Diggelmann, R. M. Locksley, H. R. MacDonald, and J. A. Louis. 1997. IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549[CrossRef][Medline].
12. Launois, P., T. Ohteki, K. Swihart, H. R. MacDonald, and J. A. Louis. 1995. In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur. J. Immunol. 25:3298-3307[Medline].
13. Launois, P., K. G. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317-3324[Abstract].
14. Locksley, R. M., S. Pingel, D. Lacy, A. E. Wakil, M. Bix, and D. J. Fowell. 1999. Susceptibility to infectious diseases: Leishmania as a paradigm. J. Infect. Dis. 179(Suppl. 2):S305-S308.
15. Long, G. W., T. R. Jones, L. S. Rickman, L. Fries, J. Egan, B. Wellde, and S. L. Hoffman. 1994. Acridine orange diagnosis of Plasmodium falciparum: evaluation after experimental infection. Am. J. Trop. Med. Hyg. 51:613-616.
16. Mottram, J. C., D. R. Brooks, and G. H. Coombs. 1998. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. 1:455-460[CrossRef][Medline].
17. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566[Abstract/Free Full Text].
18. Pingel, S., P. Launois, D. J. Fowell, C. W. Turck, S. Southwood, A. Sette, N. Glaichenhaus, J. A. Louis, and R. M. Locksley. 1999. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J. Exp. Med. 189:1111-1120[Abstract/Free Full Text].
19. Prina, E., T. Lang, N. Glaichenhaus, and J. C. Antoine. 1996. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J. Immunol. 156:4318-4327[Abstract].
20. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177[CrossRef][Medline].
21. Russell, D. G., S. Xu, and P. Chakraborty. 1992. Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages. J. Cell Sci. 103:1193-1210[Abstract/Free Full Text].
22. Sacks, D. L., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419[Abstract/Free Full Text].
23. Satoskar, A., H. Bluethmann, and J. Alexander. 1995. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 63:4894-4899[Abstract].
24. Satoskar, A., F. Brombacher, W. J. Dai, I. McInnes, F. Y. Liew, J. Alexander, and W. Walker. 1997. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis. J. Immunol. 159:5005-5013[Abstract].
25. Stamm, L. M., A. Raisanen-Sokolowski, M. Okano, M. E. Russell, J. R. David, and A. R. Satoskar. 1998. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J. Immunol. 161:6180-6188[Abstract/Free Full Text].


Infection and Immunity, January 2001, p. 617-621, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.617-621.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bryson, K., Besteiro, S., McGachy, H. A., Coombs, G. H., Mottram, J. C., Alexander, J. (2009). Overexpression of the Natural Inhibitor of Cysteine Peptidases in Leishmania mexicana Leads to Reduced Virulence and a Th1 Response. Infect. Immun. 77: 2971-2978 [Abstract] [Full Text]  
  • Nanda, N. K., Bikoff, E. K. (2005). DM Peptide-Editing Function Leads to Immunodominance in CD4 T Cell Responses In Vivo. J. Immunol. 175: 6473-6480 [Abstract] [Full Text]  
  • Buxbaum, L. U., Denise, H., Coombs, G. H., Alexander, J., Mottram, J. C., Scott, P. (2003). Cysteine Protease B of Leishmania mexicana Inhibits Host Th1 Responses and Protective Immunity. J. Immunol. 171: 3711-3717 [Abstract] [Full Text]  
  • Coelho, E. A. F., Tavares, C. A. P., Carvalho, F. A. A., Chaves, K. F., Teixeira, K. N., Rodrigues, R. C., Charest, H., Matlashewski, G., Gazzinelli, R. T., Fernandes, A. P. (2003). Immune Responses Induced by the Leishmania (Leishmania) donovani A2 Antigen, but Not by the LACK Antigen, Are Protective against Experimental Leishmania (Leishmania) amazonensis Infection. Infect. Immun. 71: 3988-3994 [Abstract] [Full Text]  
  • Colmenares, M., Kima, P. E., Samoff, E., Soong, L., McMahon-Pratt, D. (2003). Perforin and Gamma Interferon Are Critical CD8+ T-Cell-Mediated Responses in Vaccine-Induced Immunity against Leishmania amazonensis Infection. Infect. Immun. 71: 3172-3182 [Abstract] [Full Text]  
  • Denise, H., McNeil, K., Brooks, D. R., Alexander, J., Coombs, G. H., Mottram, J. C. (2003). Expression of Multiple CPB Genes Encoding Cysteine Proteases Is Required for Leishmania mexicana Virulence In Vivo. Infect. Immun. 71: 3190-3195 [Abstract] [Full Text]  
  • Pollock, K. G. J., McNeil, K. S., Mottram, J. C., Lyons, R. E., Brewer, J. M., Scott, P., Coombs, G. H., Alexander, J. (2003). The Leishmania mexicana Cysteine Protease, CPB2.8, Induces Potent Th2 Responses. J. Immunol. 170: 1746-1753 [Abstract] [Full Text]  
  • Aguilar Torrentera, F., Laman, J. D., Van Meurs, M., Adorini, L., Muraille, E., Carlier, Y. (2002). Endogenous Interleukin-12 Is Critical for Controlling the Late but Not the Early Stage of Leishmania mexicana Infection in C57BL/6 Mice. Infect. Immun. 70: 5075-5080 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torrentera, F. A.
Right arrow Articles by Carlier, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torrentera, F. A.
Right arrow Articles by Carlier, Y.